Edition:
United States

Yabao Pharmaceutical Group Co Ltd (600351.SS)

600351.SS on Shanghai Stock Exchange

7.85CNY
17 Nov 2017
Change (% chg)

¥-0.36 (-4.38%)
Prev Close
¥8.21
Open
¥8.21
Day's High
¥8.24
Day's Low
¥7.84
Volume
6,222,603
Avg. Vol
4,543,646
52-wk High
¥10.47
52-wk Low
¥6.97

Latest Key Developments (Source: Significant Developments)

Yabao Pharmaceutical Group sees 2017 Q1-Q3 net profit to increase by 100 pct to 120 pct
Tuesday, 26 Sep 2017 11:37pm EDT 

Sept 27(Reuters) - Yabao Pharmaceutical Group Co Ltd <600351.SS> ::* Says net profit for 2017 Q1-Q3 to increase by 100 percent to 120 percent, compared to net profit of 2016 Q1-Q3 (68.8 million yuan).* Says increased sales revenue as main reason for the forecast.  Full Article

Yabao Pharmaceutical Group gets approval to conduct drug clinical trials for diabetes
Monday, 31 Jul 2017 01:09am EDT 

July 29 (Reuters) - Yabao Pharmaceutical Group Co Ltd <600351.SS>:* Says it gets an approval to conduct drug clinical trials of SY-008 which can be used for treatment of diabetes, from China Food and Drug Administration.  Full Article

Yabao Pharmaceutical Group sees FY 2016 net profit down 70 pct to 90 pct
Monday, 23 Jan 2017 03:56am EST 

Yabao Pharmaceutical Group <600351.SS> :Says it sees 2016 net profit down 70 percent to 90 percent, from a year ago.  Full Article

Yabao Pharmaceutical Group sees 2016 Q1~Q3 net profit to decrease by 50 pct to 70 pct
Wednesday, 12 Oct 2016 06:02am EDT 

Yabao Pharmaceutical Group Co Ltd <600351.SS> :sees 2016 Q1~Q3 net profit to decrease by 50 percent to 70 percent, compared to net profit of Q1~Q3 in 2015(206.7 million yuan).  Full Article

Yabao Pharmaceutical Group appoints Grant Thornton as new auditor for 2016
Thursday, 22 Sep 2016 05:03am EDT 

Yabao Pharmaceutical Group <600351.SS>:Says it appoints Grant Thornton as new auditor for 2016.  Full Article

Yabao Pharmaceutical Group to buy 75 pct stake in Shanghai Qingsong Pharmacy at 611.8 mln yuan
Thursday, 22 Sep 2016 04:56am EDT 

Yabao Pharmaceutical Group <600351.SS>:Says it will buy 75 percent stake in Shanghai Qingsong Pharmacy Co Ltd at 611.8 million yuan.  Full Article

Yabao Pharmaceutical Group to pay 2015 div on June 29
Wednesday, 22 Jun 2016 02:00am EDT 

Yabao Pharmaceutical Group <600351.SS> Co.Ltd: Says it will pay cash dividend of 1 yuan per 10 shares (before tax) to shareholders for 2015 as a record of June 28 .Says the company's shares will be traded ex-right and ex-dividend on June 29 and the dividend will be paid on June 29.  Full Article

Yabao Pharmaceutical Group signs technology development and transfer contract
Thursday, 28 Apr 2016 08:00pm EDT 

Yabao Pharmaceutical Group Co Ltd:Signs technology development and transfer contract with Shanghai-based pharmacy company.Shanghai-based pharmacy company in charge of technology development of pharmaceutical raw materials (cangrelor and pramipexole) manufacture which was commissioned by the company.Technology development fee of 5 mln yuan and 4.5 mln yuan, respectively.The company to invest 2 mln yuan, to buy exclusive technology of lipoic acid raw material process improvement from the Shanghai-based pharmacy company.  Full Article

Yabao Pharmaceutical Group unit passes FDA approval
Tuesday, 19 Apr 2016 08:00pm EDT 

Yabao Pharmaceutical Group Co Ltd:Says its unit, Yabao Pharmaceutical Co., Ltd. Beijing, receives approval for its galanthamine hydrobromide tablets from U.S Food and Drug Administration.Yabao Pharmaceutical Co., Ltd. Beijing will be able to sell its galanthamine hydrobromide tablets in the United States after receiving the FDA approval.  Full Article

Yabao Pharmaceutical Group announces 2015 dividend payment
Wednesday, 30 Mar 2016 08:00pm EDT 

Yabao Pharmaceutical Group Co Ltd:To pay cash dividend of 1 yuan per 10 shares (before tax) to shareholders for 2015.  Full Article

BRIEF-Yabao Pharma's controlling shareholder plans exchangeable bonds issue

* Says controlling shareholder plans to raise up to 500 million yuan ($75.33 million) in exchangeable bonds issue